Información del artículo
El Texto completo está disponible en PDF
Bibliografía
[1.]
E. Lindqvist, K. Eberhardt.
Mortality in rheumatoid arthritis patients with disease onset in the 1980s.
Ann Rheum Dis, 58 (1999), pp. 11-14
[2.]
E.J. Kroot, M.A. Van Leeuwen, M.H. Van Rijswijk, M.L. Prevoo, M.A. Van’t Hof, L.B. Van De Putte, et al.
No increased mortality in patients with rheumatoid arthritis: up to 10 years of follow up from disease onset.
Ann Rheum Dis, 59 (2000), pp. 954-958
[3.]
N. Goodson.
Coronary artery disease and rheumatoid arthritis.
Curr Opin Rheumatol, 14 (2002), pp. 115-120
[4.]
P.A. Reilly, J.A. Cosh, P.J. Maddison, J.J. Rasker, A.J. Silman.
Mortality and survival in rheumatoid arthritis: a 25 year prospective study of 100 patients.
Ann Rheum Dis, 49 (1990), pp. 363-369
[5.]
L.T. Jacobsson, W.C. Knowler, S. Pillemer, R.L. Hanson, D.J. Pettitt, R.G. Nelson, et al.
Rheumatoid arthritis and mortality. A longitudinal study in Pima Indians.
Arthritis Rheum, 36 (1993), pp. 1045-1053
[6.]
D.P. Symmons, M.A. Jones, D.L. Scott, P. Prior.
Longterm mortality outcome in patients with rheumatoid arthritis: early presenters continue to do well.
J Rheumatol, 25 (1998), pp. 1072-1077
[7.]
S. Wallberg-Jonsson, M.L. Ohman, S.R. Dahlqvist.
Cardiovascular morbidity and mortality in patients with seropositive rheumatoid arthritis in Northern Sweden.
J Rheumatol, 24 (1997), pp. 445-451
[8.]
N.J. Goodson, N.J. Wiles, M. Lunt, E.M. Barrett, A.J. Silman, D.P. Symmons.
Mortality in early inflammatory polyarthritis: cardiovascular mortality is increased in seropositive patients.
Arthritis Rheum, 46 (2002), pp. 2010-2019
[9.]
T.R. Mikuls, K.G. Saag, L.A. Criswell, L.A. Merlino, R.A. Kaslow, B.J. Shelton, et al.
Mortality risk associated with rheumatoid arthritis in a prospective cohort of older women: results from the Iowa Women's Health Study.
Ann Rheum Dis, 61 (2002), pp. 994-999
[10.]
D. Van Schaardenburg, J.M. Hazes, A. De Boer, A.H. Zwinderman, K.A. Meijers, F.C. Breedveld.
Outcome of rheumatoid arthritis in relation to age and rheumatoid factor at diagnosis.
J Rheumatol, 20 (1993), pp. 45-52
[11.]
C. Turesson, L. Jacobsson, U. Bergstrom.
Extra-articular rheumatoid arthritis: prevalence and mortality.
Rheumatology (Oxford), 38 (1999), pp. 668-674
[12.]
J.C. Chehata, A.B. Hassell, S.A. Clarke, D.L. Mattey, M.A. Jones, P.W. Jones, et al.
Mortality in rheumatoid arthritis: relationship to single and composite measures of disease activity.
Rheumatology (Oxford), 40 (2001), pp. 447-452
[13.]
A.E. Voskuyl, A.H. Zwinderman, M.L. Westedt, J.P. Vandenbroucke, F.C. Breedveld, J.M. Hazes.
The mortality of rheumatoid vasculitis compared with rheumatoid arthritis.
Arthritis Rheum, 39 (1996), pp. 266-271
[14.]
S. Van Doornum, G. McColl, I.P. Wicks.
Accelerated atherosclerosis: an extraarticular feature of rheumatoid arthritis?.
Arthritis Rheum, 46 (2002), pp. 862-873
[15.]
F. Wolfe, D.M. Mitchell, J.T. Sibley, J.F. Fries, D.A. Bloch, C.A. Williams, et al.
The mortality of rheumatoid arthritis.
Arthritis Rheum, 37 (1994), pp. 481-494
[16.]
A.J. Silman, J. Newman, A.J. MacGregor.
Cigarette smoking increases the risk of rheumatoid arthritis. Results from a nationwide study of disease discordant twins.
Arthritis Rheum, 39 (1996), pp. 732-735
[17.]
B. Masdottir, T. Jonsson, V. Manfredsdottir, A. Vikingsson, A. Brekkan, H. Valdimarsson.
Smoking, rheumatoid factor isotypes and severity of rheumatoid arthritis.
Rheumatology (Oxford), 39 (2000), pp. 1202-1205
[18.]
N.J. Goodson, A.J. Silman, D.J. Pattison, M. Lunt, D. Bunn, R. Luben, et al.
Traditional cardiovascular risk factors measured prior to the onset of inflammatory polyarthritis.
Rheumatology (Oxford), 43 (2004), pp. 731-736
[19.]
I. Del Rincon, K. Williams, M.P. Stern, G.L. Freeman, D.H. O’Leary, A. Escalante.
Association between carotid atherosclerosis and markers of inflammation in rheumatoid arthritis patients and healthy subjects.
Arthritis Rheum, 48 (2003), pp. 1833-1840
[20.]
C. Gonzalez-Juanatey, J. Llorca, A. Testa, J. Revuelta, C. Garcia-Porrua, M.A. Gonzalez-Gay.
Increased prevalence of severe subclinical atherosclerotic findings in long-term treated rheumatoid arthritis patients without clinically evident atherosclerotic disease.
Medicine (Baltimore), 82 (2003), pp. 407-413
[21.]
C. Gonzalez-Juanatey, M.A. Gonzalez-Gay.
Rheumatoid arthritis and accelerated atherogenesis.
Circulation, 109 (2004), pp. e328
[22.]
M.A. Gonzalez-Gay, C. Gonzalez-Juanatey, A. Pineiro, C. Garcia-Porrua, A. Testa, J. Llorca.
High-grade C-reactive protein elevation correlates with accelerated atherogenesis in patients with rheumatoid arthritis.
J Rheumatol, 32 (2005), pp. 1219-1223
[23.]
M.A. Gonzalez-Gay, C. Gonzalez-Juanatey, J. Martin.
Rheumatoid arthritis: a disease associated with accelerated atherogenesis.
Semin Arthritis Rheum, 35 (2005), pp. 8-17
[24.]
A. Khera, J.A. De Lemos, R.M. Peshock, H.S. Lo, H.G. Stanek, S.A. Murphy, et al.
Relationship between C-reactive protein and subclinical atherosclerosis: the Dallas Heart Study.
Circulation, 113 (2006), pp. 38-43
[25.]
N. Goodson, J. Marks, M. Lunt, D. Symmons.
Cardiovascular admissions and mortality in an inception cohort of patients with rheumatoid arthritis with onset in the 1980s and 1990s.
Ann Rheum Dis, 64 (2005), pp. 1595-1601
[26.]
P.J. Nicola, H. Maradit-Kremers, V.L. Roger, S.J. Jacobsen, C.S. Crowson, K.V. Ballman, et al.
The risk of congestive heart failure in rheumatoid arthritis: a population-based study over 46 years.
Arthritis Rheum, 52 (2005), pp. 412-420
[27.]
S. Wallberg-Jonsson, H. Johansson, M.L. Ohman, S. Rantapaa-Dahlqvist.
Extent of inflammation predicts cardiovascular disease and overall mortality in seropositive rheumatoid arthritis. A retrospective cohort study from disease onset.
J Rheumatol, 26 (1999), pp. 2562-2571
[28.]
L.A. Garcia Rodriguez, A. Gonzalez-Perez.
Long-term use of non-steroidal anti-inflammatory drugs and the risk of myocardial infarction in the general population.
BMC Med, 3 (2005), pp. 17
[29.]
I. Del Rincon, D.H. O’Leary, R.W. Haas, A. Escalante.
Effect of glucocorticoids on the arteries in rheumatoid arthritis.
Arthritis Rheum, 50 (2004), pp. 3813-3822
[30.]
R.B. Landewe, F.C. Breedveld, B.A. Dijkmans.
Methotrexate treatment and mortality in rheumatoid arthritis.
Lancet, 360 (2002), pp. 1095-1096
[31.]
H.K. Choi, M.A. Hernan, J.D. Seeger, J.M. Robins, F. Wolfe.
Methotrexate and mortality in patients with rheumatoid arthritis: a prospective study.
Lancet, 359 (2002), pp. 1173-1177
[32.]
D.A. Redelmeier, S.H. Tan, G.L. Booth.
The treatment of unrelated disorders in patients with chronic medical diseases.
N Engl J Med, 338 (1998), pp. 1516-1520
[33.]
L. Colgazier, F. Wolfe, K. Michaud.
Rheumatoid arthritis (RA) patients are less likely to be treated with prophylactic aspirin despite an increased risk of myocardial infarction.
Meeting of the American College of Rheumatology, 52, pp. S704
[34.]
E. Krishnan, V.B. Lingala, G. Singh.
Declines in mortality from acute myocardial infarction in successive incidence and birth cohorts of patients with rheumatoid arthritis.
Circulation, 110 (2004), pp. 1774-1779
[35.]
K. Michaud, F. Wolfe.
Reduced mortality among RA patients treated with anti-TNF therapy and methotrexate.
Meeting of the American College of Rheumatology,
[36.]
U. Bergstrom, C. Book, Y. Lindroth, L. Marsal, T. Saxne, L. Jacobsson.
Lower disease activity and disability in Swedish patients with rheumatoid arthritis in 1995 compared with 1978.
Scand J Rheumatol, 28 (1999), pp. 160-165
[37.]
T. Sokka, T. Mottonen, P. Hannonen.
Mortality in early “sawtooth” treated rheumatoid arthritis patients during the first 8-14 years.
Scand J Rheumatol, 28 (1999), pp. 282-287
Copyright © 2006. Elsevier España S.L. Barcelona
